Transdermals
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
10
NCT01887379
Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 30, 2013
Completion: Aug 31, 2013
Loading map...